| Views | |
|---|---|
| Iron(III)‐tCDTA derivatives as MRI contrast agents: Increased T 1 relaxivities at higher magnetic field strength and pH sensing | 140 |
| March 2025 | April 2025 | May 2025 | June 2025 | July 2025 | August 2025 | September 2025 | |
|---|---|---|---|---|---|---|---|
| Iron(III)‐tCDTA derivatives as MRI contrast agents: Increased T 1 relaxivities at higher magnetic field strength and pH sensing | 4 | 13 | 0 | 3 | 11 | 0 | 3 |
| Views | |
|---|---|
| 2020_Xie_etal.pdf | 65 |
